Compile Data Set for Download or QSAR
Report error Found 341 Enz. Inhib. hit(s) with all data for entry = 2542
TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418652BDBM418652(4-{[4-({3- [methyl(methylsulfonyl)amino]benzyl} am...)
Affinity DataIC50: 0.380nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418649BDBM418649(N-methyl-4-{[4-({2- [methyl(methylsulfonyl)amino]b...)
Affinity DataIC50: 0.590nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418650BDBM418650(N-ethyl-4-({4-[({3- [methyl(methylsulfonyl)amino]p...)
Affinity DataIC50: 0.590nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418651BDBM418651(ethyl [4-({4-[({2- [methyl(methylsulfonyl)amino]py...)
Affinity DataIC50: 0.590nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418609BDBM418609(N-methyl-4-({4-[({2- [methyl(methylsulfonyl)amino]...)
Affinity DataIC50: 0.590nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418610BDBM418610(N-methyl-4-({4-[({6-methyl-2- [methyl(methylsulfon...)
Affinity DataIC50: 0.590nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418604BDBM418604(3-methoxy-4-({4-[({2- [methyl(methylsuffonyl)amino...)
Affinity DataIC50: 0.590nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418605BDBM418605(3-methoxy-4-({4-[({6-methyl-2- [methyl(methylsulfo...)
Affinity DataIC50: 0.590nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418606BDBM418606(N-[3-({[2-anilino-5- (trifluoromethyl)pyrimidin-4-...)
Affinity DataIC50: 0.590nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418607BDBM418607(N-[3-({[2-anilino-5- (trifluoromethyl)pyrimidin-4-...)
Affinity DataIC50: 0.590nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418634BDBM418634(N-[5-({[2-anilino-5- (trifluoromethyl)pyrimidin-4-...)
Affinity DataIC50: 0.590nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418603BDBM418603(3-methoxy-4-{[4-{[3- (methylsulfonyl)benzyl]amino}...)
Affinity DataIC50: 0.590nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418597BDBM418597(methyl 4-({4-[({2- [methyl(methylsulfonyl)amino]py...)
Affinity DataIC50: 0.590nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418624BDBM418624(N-[2-(([2-anilino-5- (trifluoromethyl)pyrimidin-4-...)
Affinity DataIC50: 0.590nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418656BDBM418656(N-[3-({[2-{[4-(aminomethyl)phenyl]amino}- 5-(trifl...)
Affinity DataIC50: 0.590nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418659BDBM418659(4-{[4-({2-methyl-6- [methyl(methylsulfonyl)amino]b...)
Affinity DataIC50: 0.590nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418653BDBM418653(N-methyl-4-{[4-({3- [methyl(methylsulfonyl)amino]b...)
Affinity DataIC50: 0.590nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418655BDBM418655(N-methyl-4-({4-[({6-methyl-4- [methyl(methylsulfon...)
Affinity DataIC50: 0.590nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418856BDBM418856(US10450297, Example 356 | N-[2-({[2-({4-[(1S)-1- a...)
Affinity DataIC50: 0.593nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418868BDBM418868(US10450297, Example 368 | 3-fluoro-N-methyl-4-({4-...)
Affinity DataIC50: 0.595nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418801BDBM418801(N-[3-({[2-{[3-(1- hydroxyethyl)phenyl]amino}-5- (t...)
Affinity DataIC50: 0.595nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418866BDBM418866(US10450297, Example 366 | N-[3-({4-[({2- [methyl(m...)
Affinity DataIC50: 0.595nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418860BDBM418860(US10450297, Example 360 | 2-chloro-4-({4-[({3- [me...)
Affinity DataIC50: 0.595nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418862BDBM418862(US10450297, Example 362 | N-[2-({[2-({4-[(1R)-1- a...)
Affinity DataIC50: 0.595nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418862BDBM418862(US10450297, Example 362 | N-[2-({[2-({4-[(1R)-1- a...)
Affinity DataIC50: 0.595nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418888BDBM418888(US10450297, Example 388 | N-{3-[({2-((4-{[(2- meth...)
Affinity DataIC50: 0.595nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418889BDBM418889(US10450297, Example 389 | N-[3-({[2-{[4-({[2-hydro...)
Affinity DataIC50: 0.595nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418884BDBM418884(US10450297, Example 384 | N-[3-({[2-({4- [(isoprop...)
Affinity DataIC50: 0.595nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418820BDBM418820(2-fluoro-4-({4-[({2- [methyl(methylsulfonyl)amino]...)
Affinity DataIC50: 0.595nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418822BDBM418822(3-fluoro-4-({4-[({2- [methyl(methylsulfonyl)amino]...)
Affinity DataIC50: 0.595nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418817BDBM418817(US10450297, Example 317 | US10450297, Example 318 ...)
Affinity DataIC50: 0.595nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418883BDBM418883(US10450297, Example 383 | N-{3-[({2-[(4-{[(2- hydr...)
Affinity DataIC50: 0.595nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418819BDBM418819(N-[3-({[2-{[4- (hydroxymethyl)phenyl]amino}-5- (tr...)
Affinity DataIC50: 0.595nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418814BDBM418814(N-methyl-N-[3-({[2-{[4-(1H-tetrazol-5- yl)phenyl]a...)
Affinity DataIC50: 0.595nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418840BDBM418840(2-methyl-4-{[4-({3- [methyl(methylsulfonyl)amino]b...)
Affinity DataIC50: 0.595nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418841BDBM418841(US10450297, Example 341 | 3-methyl-4-({4-[({2- [me...)
Affinity DataIC50: 0.595nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418907BDBM418907(US10450297, Example 407 | N'-hydroxy-4-({4-[({2- [...)
Affinity DataIC50: 0.595nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418836BDBM418836(US10450297, Example 336 | US10450297, Example 337 ...)
Affinity DataIC50: 0.595nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418836BDBM418836(US10450297, Example 336 | US10450297, Example 337 ...)
Affinity DataIC50: 0.595nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418902BDBM418902(US10450297, Example 402 | N,2-dimethyl-4-({4-[({2-...)
Affinity DataIC50: 0.595nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418838BDBM418838(US10450297, Example 338 | US10450297, Example 339 ...)
Affinity DataIC50: 0.595nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418838BDBM418838(US10450297, Example 338 | US10450297, Example 339 ...)
Affinity DataIC50: 0.595nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418834BDBM418834(US10450297, Example 334 | 2-methyl-4-({4-[({2- [me...)
Affinity DataIC50: 0.595nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418834BDBM418834(US10450297, Example 334 | 2-methyl-4-({4-[({2- [me...)
Affinity DataIC50: 0.595nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418894BDBM418894(US10450297, Example 394 | 2-hydroxy-4-({4-[({2- [m...)
Affinity DataIC50: 0.595nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418793BDBM418793(N-methyl-N-{3-[({2-[(5-morpholin-4- ylpyridin-2-yl...)
Affinity DataIC50: 0.595nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418794BDBM418794(3-({4-[({6-methyl-2- [methyl(methylsulfonyl)amino]...)
Affinity DataIC50: 0.595nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418858BDBM418858(US10450297, Example 358 | 2-chloro-4-({4-[({2- [me...)
Affinity DataIC50: 0.595nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418859BDBM418859(US10450297, Example 359 | 2-chloro-4-({4-[({3- [me...)
Affinity DataIC50: 0.595nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

TargetFocal adhesion kinase 1 [410-689](Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 418852BDBM418852(N-[2-({[2-({4-[(1R)-1- aminoethyl]phenyl}amino)-5-...)
Affinity DataIC50: 0.595nMAssay Description:The in vitro activity of the compounds of the compounds of the invention may be determined by the following procedure. More particularly, the followi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/31/2020
Entry Details
US Patent

Displayed 1 to 50 (of 341 total ) | Next | Last >>
Jump to: